New York, NY -- (SBWIRE) -- 01/16/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Pacific Biosciences of California (NASDAQ:PACB), Synta Pharmaceuticals Corp (NASDAQ:SNTA), China Ming Yang Wind Power Group Ltd (NYSE:MY), Tengion, Inc (OTCMKTS:TNGN)
Pacific Biosciences of California (NASDAQ:PACB) showed a volume of 1.39 million shares by the end of last trade whereas the average volume of the stock remained 658,906 shares. The stock opened the session at $5.34 but then moved to $5.98. At that price, the stock showed a positive performance of 11.78%. Pacific Biosciences, Inc. develops Deoxyribonucleic Acid (DNA) sequencing platform. The Company designs and develops a method for single-molecule DNA sequencing that was developed through collaboration between the research groups of Harold Craighead and Watt Webb at Cornell University, United States.
Will PACB Continue To Move Higher? Find Out Here
Synta Pharmaceuticals Corp (NASDAQ:SNTA) opened the session at $6.37 and closed the session at $6.32. The stock showed a negative performance of -1.40% in previous trading session. Traded with volume of 1.37 million shares in the prior session and the average volume of the stock remained 1.87 million shares. Synta Pharmaceuticals Corp. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing small molecule drugs to severe the medical conditions of the patients with cancer and inflammatory diseases. As of December 31, 2011, it had two drug candidates in clinical trials for treating multiple types of cancer and several drug candidates in the preclinical-stage of development. Its drug candidates are discovered and developed internally,
Has SNTA Found The Bottom And Ready To Gain Momentum? Find Out Here
China Ming Yang Wind Power Group Ltd (NYSE:MY) opened the session at $2.35 and closed the session at $2.52. The stock showed a positive performance of 5.88% in previous trading session. The beta of the stock remained 2.67. China Ming Yang Wind Power Group Limited is a wind turbine manufacturer in China, focusing on designing, manufacturing, selling and servicing megawatt-class wind turbines. The Company’s products consist of basic models of wind turbines, each with a rated power capacity of 1.5 megawatt (MW); wind turbines with a rated power capacity of 2.0MW, and 2.5/3.0MW SCD wind turbines.
Why Should Investors Buy MY After The Recent Gain? Just Go Here and Find Out
Tengion, Inc (OTCMKTS:TNGN) the stock advanced 17.39% and finished the session at $0.270. Traded with volume of 1.36 million shares in the prior session and the average volume of the stock remained 145,197.00 shares. The beta of the stock remained 2.66. Tengion, Inc. (Tengion) is a regenerative medicine company focused on discovering, developing, manufacturing and commercializing a range of replacement organs and tissues, or neo-organs and neo-tissues. The Company focuses on creating these functional neo-organs and neo-tissues using a patient’s own cells, or autologous cells, in conjunction with its Organ Regeneration Platform.
Will TNGN Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)